Nova Patents
NO20006090D0

PYRROLO¬2,3d PYRIMIDINE COMPOSITIONS AND THEIR USE

Abstract

Novel deazapurines are disclosed which are useful for the treatment of adenosine receptor stimulated diseases.

Term

No projected expiry on record.

  1. Priority
  2. Filed and published
  3. Today

74 members in 35 offices

This recordMember, by publication datePriority claim25 more offices are in the list below

Priority claims16

Priority claims
DocumentOfficeKindDate
8770298United States of AmericaP
8770298United States of AmericaP
12321699United States of AmericaP
12321699United States of AmericaP
12652799United States of AmericaP
12652799United States of AmericaP
9912135United States of AmericaW
9912135United States of AmericaW
8770298–––
9912135–––
12321699–––
12652799–––
US19980087702P–––
US19990123216P–––
US19990126527P–––
WO1999US12135–––

Members74

Family members, oldest first
DocumentOfficeKind
CA2334200A1CanadaA1
WO9962518A1World Intellectual Property Organization (WIPO)A1
AU4226599AAustraliaA
NO20006090D0This recordNorwayD0
NO20006090LNorwayL
BR9911612ABrazilA
EP1082120A1European Patent Office (EPO)A1
ID27600AIndonesiaA
CA2393179A1CanadaA1
WO0139777A1World Intellectual Property Organization (WIPO)A1
AU2427001AAustraliaA
TR200003513T2TürkiyeT2
EA200001245A1Eurasian Patent Organization (EAPO)A1
KR20010083042ARepublic of KoreaA
CN1311680AChinaA
WO0139777A8World Intellectual Property Organization (WIPO)A8
IL139787D0IsraelD0
HU0103836A2HungaryA2
US2002028782A1United States of AmericaA1
PL347020A1PolandA1
CZ20004443A3CzechiaA3
AR020590A1ArgentinaA1
JP2002516861AJapanA
KR20020064327ARepublic of KoreaA
EP1246623A1European Patent Office (EPO)A1
IL149935D0IsraelD0
MXPA00011889AMexicoA
EP1246623A4European Patent Office (EPO)A4
MXPA02005357AMexicoA
HU0103836A3HungaryA3
JP2003519102AJapanA
HK1050319A1Hong Kong, ChinaA1
EA003604B1Eurasian Patent Organization (EAPO)B1
AU763658B2AustraliaB2
YU76100AYugoslavia, later Serbia and Montenegro (until 2006)A
US6686366B1United States of AmericaB1
AR034111A1ArgentinaA1
NZ508314ANew ZealandA
DZ3101A1AlgeriaA1
US6800633B2United States of AmericaB2
ZA200204153BSouth AfricaB
DZ2805A1AlgeriaA1
US2005043332A1United States of AmericaA1
US6878716B1United States of AmericaB1
UA72736C2UkraineC2
AP1411AAfrican Regional Intellectual Property Organization (ARIPO)A
TWI242435BTaiwan Province of ChinaB
OA12147AAfrican Intellectual Property Organization (OAPI)A
AU784878B2AustraliaB2
EP1246623B1European Patent Office (EPO)B1
AT335489TAustriaT
DE60030002D1GermanyD1
DK1246623T3DenmarkT3
EP1731520A1European Patent Office (EPO)A1
PT1246623EPortugalE
DE60030002T2GermanyT2
ES2269217T3SpainT3
HK1050319BHong Kong, ChinaB
SI1246623T1SloveniaT1
KR100722194B1Republic of KoreaB1
TWI287015BTaiwan Province of ChinaB
NO325233B1NorwayB1
KR100840727B1Republic of KoreaB1
US7429574B2United States of AmericaB2
EP2011499A2European Patent Office (EPO)A2
US2009082369A1United States of AmericaA1
CN100528874CChinaC
PL204628B1PolandB1
EP2011499A3European Patent Office (EPO)A3
JP4611524B2JapanB2
CA2334200CCanadaC
CZ302486B6CzechiaB6
IL199869D0IsraelD0
CY1107653T1CyprusT1